Immunomodulating tumor necrosis factor receptor 25 (TNFR25) agonists, antagonists and immunotoxins

Details for Australian Patent Application No. 2006284922 (hide)

Owner University of Miami

Inventors Podack, Eckhard; Levy, Robert; Deyev, Vadim

Agent Watermark

Pub. Number AU-B-2006284922

PCT Pub. Number WO2007/027751

Priority 60/712,084 30.08.05 US

Filing date 30 August 2006

Wipo publication date 8 March 2007

Acceptance publication date 19 January 2012

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

Event Publications

3 April 2008 PCT application entered the National Phase

  PCT publication WO2007/027751 Priority application(s): WO2007/027751

19 January 2012 Application Accepted

  Published as AU-B-2006284922

17 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006284926-Human G protein-coupled receptor and modulators thereof for the treatment of atherosclerosis and atherosclerotic disease and for the treatment of conditions related to MCP-1 expression

2006284916-Multimedia color management system